A Novel Cream Formulation Containing Nicotinamide 4%, Arbutin 3%, Bisabolol 1%, and Retinaldehyde 0.05% for Treatment of Epidermal MelasmaNovember 12, 2015Pigmentation Disorders
Coding for Biopsies, Shave Removals, and ExcisionsNovember 12, 2015Practice ManagementAesthetic DermatologyBusiness of Medicine
Dermatology NewsHigh IgE linked to poor treatment outcomes in AD patientsNovember 12, 2015Atopic DermatitisPediatrics
Dermatology NewsSuccessive gene mutations causing melanoma progression identifiedNovember 11, 2015Melanoma
Dermatology NewsSurvivors of childhood cancers at increased risk for autoimmune diseasesNovember 10, 2015PediatricsRare Diseases
Dermatology NewsCobimetinib approved as add-on to vemurafenib for advanced melanomaNovember 10, 2015Melanoma
Dermatology NewsEczema associated with childhood speech disorderNovember 10, 2015Atopic DermatitisPediatrics
Dermatology NewsVIDEO: Psoriasis, psoriatic arthritis improve with bariatric surgeryNovember 10, 2015Psoriatic ArthritisPsoriasis
Dermatology NewsShingles vaccine protection lasted 5-6 years in autoimmune disease patientsNovember 7, 2015Psoriatic ArthritisInfectious DiseasesPsoriasis
Dermatology NewsStroke risk rose in autoimmune disease patients after herpes zosterNovember 7, 2015Infectious DiseasesPsoriasisPsoriatic Arthritis
Dermatology NewsAnswers elusive in quest for better chlamydia treatmentNovember 7, 2015Infectious Diseases
Dermatology NewsSupreme Court agrees to hear ACA contraceptive mandate opt-out challengeNovember 6, 2015Practice ManagementHealth PolicyBusiness of Medicine